Henry Schein, Inc. (0L3C.L)
USD 65.14
(1.15%)
USD 65.14
(1.15%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.81 Billion USD | -7.54% |
| 2022 | 1.96 Billion USD | 5.47% |
| 2021 | 1.86 Billion USD | 23.05% |
| 2020 | 1.51 Billion USD | 5.86% |
| 2019 | 1.42 Billion USD | -27.5% |
| 2018 | 1.97 Billion USD | 1.91% |
| 2017 | 1.93 Billion USD | 18.22% |
| 2016 | 1.63 Billion USD | 8.33% |
| 2015 | 1.5 Billion USD | 13.72% |
| 2014 | 1.32 Billion USD | 6.19% |
| 2013 | 1.25 Billion USD | 3.9% |
| 2012 | 1.2 Billion USD | 26.97% |
| 2011 | 947.84 Million USD | 8.92% |
| 2010 | 870.2 Million USD | 12.26% |
| 2009 | 775.19 Million USD | 5.95% |
| 2008 | 731.65 Million USD | 9.73% |
| 2007 | 666.78 Million USD | 14.16% |
| 2006 | 584.1 Million USD | 15.54% |
| 2005 | 505.54 Million USD | 3.92% |
| 2004 | 486.49 Million USD | 26.09% |
| 2003 | 385.84 Million USD | 19.43% |
| 2002 | 323.08 Million USD | 10.94% |
| 2001 | 291.23 Million USD | 5.34% |
| 2000 | 276.47 Million USD | -3.2% |
| 1999 | 285.6 Million USD | 5.78% |
| 1998 | 270 Million USD | 26.88% |
| 1997 | 212.8 Million USD | 68.09% |
| 1996 | 126.6 Million USD | 31.19% |
| 1995 | 96.5 Million USD | 25.49% |
| 1994 | 76.9 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.65 Billion USD | -1.72% |
| 2024 Q1 | 1.68 Billion USD | -7.11% |
| 2023 Q1 | 1.91 Billion USD | -2.29% |
| 2023 Q3 | 1.83 Billion USD | -0.54% |
| 2023 Q2 | 1.84 Billion USD | -3.91% |
| 2023 FY | 1.81 Billion USD | -7.54% |
| 2023 Q4 | 1.81 Billion USD | -0.98% |
| 2022 Q2 | 1.82 Billion USD | -2.57% |
| 2022 Q1 | 1.87 Billion USD | 0.53% |
| 2022 FY | 1.96 Billion USD | 5.47% |
| 2022 Q4 | 1.96 Billion USD | 7.98% |
| 2022 Q3 | 1.81 Billion USD | -0.27% |
| 2021 Q3 | 1.78 Billion USD | 5.68% |
| 2021 FY | 1.86 Billion USD | 23.05% |
| 2021 Q1 | 1.62 Billion USD | 7.52% |
| 2021 Q2 | 1.68 Billion USD | 3.81% |
| 2021 Q4 | 1.86 Billion USD | 4.32% |
| 2020 Q1 | 1.32 Billion USD | -7.03% |
| 2020 Q2 | 1.4 Billion USD | 5.9% |
| 2020 Q3 | 1.46 Billion USD | 4.03% |
| 2020 Q4 | 1.51 Billion USD | 3.35% |
| 2020 FY | 1.51 Billion USD | 5.86% |
| 2019 Q1 | 1.37 Billion USD | -30.46% |
| 2019 FY | 1.42 Billion USD | -27.5% |
| 2019 Q2 | 1.36 Billion USD | -0.21% |
| 2019 Q3 | 1.35 Billion USD | -0.78% |
| 2019 Q4 | 1.42 Billion USD | 5.3% |
| 2018 Q3 | 1.93 Billion USD | 0.14% |
| 2018 Q2 | 1.93 Billion USD | -4.21% |
| 2018 Q1 | 2.01 Billion USD | 4.2% |
| 2018 FY | 1.97 Billion USD | 1.91% |
| 2018 Q4 | 1.97 Billion USD | 1.96% |
| 2017 Q1 | 1.62 Billion USD | -0.72% |
| 2017 FY | 1.93 Billion USD | 18.22% |
| 2017 Q4 | 1.93 Billion USD | 14.27% |
| 2017 Q3 | 1.69 Billion USD | 7.98% |
| 2017 Q2 | 1.56 Billion USD | -3.5% |
| 2016 Q4 | 1.63 Billion USD | 11.4% |
| 2016 Q2 | 1.48 Billion USD | -1.19% |
| 2016 Q1 | 1.5 Billion USD | -0.63% |
| 2016 FY | 1.63 Billion USD | 8.33% |
| 2016 Q3 | 1.46 Billion USD | -0.96% |
| 2015 Q4 | 1.5 Billion USD | 5.97% |
| 2015 FY | 1.5 Billion USD | 13.72% |
| 2015 Q3 | 1.42 Billion USD | 8.42% |
| 2015 Q2 | 1.31 Billion USD | 1.26% |
| 2015 Q1 | 1.29 Billion USD | -2.26% |
| 2014 Q2 | 1.25 Billion USD | 0.83% |
| 2014 Q3 | 1.28 Billion USD | 2.1% |
| 2014 Q4 | 1.32 Billion USD | 3.44% |
| 2014 Q1 | 1.24 Billion USD | -0.28% |
| 2014 FY | 1.32 Billion USD | 6.19% |
| 2013 FY | 1.25 Billion USD | 3.9% |
| 2013 Q4 | 1.25 Billion USD | 11.33% |
| 2013 Q3 | 1.12 Billion USD | 2.19% |
| 2013 Q2 | 1.09 Billion USD | -3.26% |
| 2013 Q1 | 1.13 Billion USD | -5.61% |
| 2012 Q1 | 975.79 Million USD | 2.95% |
| 2012 Q3 | 1.07 Billion USD | 9.61% |
| 2012 Q2 | 976.99 Million USD | 0.12% |
| 2012 FY | 1.2 Billion USD | 26.97% |
| 2012 Q4 | 1.2 Billion USD | 12.39% |
| 2011 Q2 | 926.72 Million USD | -0.39% |
| 2011 FY | 947.84 Million USD | 8.92% |
| 2011 Q4 | 947.84 Million USD | 2.62% |
| 2011 Q3 | 923.68 Million USD | -0.33% |
| 2011 Q1 | 930.34 Million USD | 6.91% |
| 2010 Q2 | 797.6 Million USD | -1.06% |
| 2010 FY | 870.2 Million USD | 12.26% |
| 2010 Q1 | 806.11 Million USD | 3.99% |
| 2010 Q4 | 870.2 Million USD | 2.43% |
| 2010 Q3 | 849.54 Million USD | 6.51% |
| 2009 FY | 775.19 Million USD | 5.95% |
| 2009 Q2 | 737.95 Million USD | -0.4% |
| 2009 Q3 | 770.37 Million USD | 4.39% |
| 2009 Q4 | 775.19 Million USD | 0.63% |
| 2009 Q1 | 740.94 Million USD | 1.27% |
| 2008 FY | 731.65 Million USD | 9.73% |
| 2008 Q4 | 731.65 Million USD | 0.02% |
| 2008 Q1 | 701.76 Million USD | 5.25% |
| 2008 Q2 | 693.55 Million USD | -1.17% |
| 2008 Q3 | 731.51 Million USD | 5.47% |
| 2007 Q3 | 676.55 Million USD | 16.75% |
| 2007 FY | 666.78 Million USD | 14.16% |
| 2007 Q1 | 583.23 Million USD | -0.15% |
| 2007 Q2 | 579.47 Million USD | -0.65% |
| 2007 Q4 | 666.78 Million USD | -1.44% |
| 2006 Q4 | 584.1 Million USD | 2.01% |
| 2006 FY | 584.1 Million USD | 15.54% |
| 2006 Q3 | 572.56 Million USD | 3.81% |
| 2006 Q2 | 551.55 Million USD | 7.74% |
| 2006 Q1 | 511.94 Million USD | 1.27% |
| 2005 FY | 505.54 Million USD | 3.92% |
| 2005 Q2 | 494.32 Million USD | -0.25% |
| 2005 Q3 | 483.28 Million USD | -2.23% |
| 2005 Q4 | 505.54 Million USD | 4.61% |
| 2005 Q1 | 495.57 Million USD | 1.87% |
| 2004 Q2 | 444.97 Million USD | 9.04% |
| 2004 Q4 | 486.49 Million USD | 8.15% |
| 2004 Q3 | 449.84 Million USD | 1.09% |
| 2004 Q1 | 408.07 Million USD | 5.76% |
| 2004 FY | 486.49 Million USD | 26.09% |
| 2003 FY | 385.84 Million USD | 19.43% |
| 2003 Q4 | 385.84 Million USD | 3.7% |
| 2003 Q3 | 372.08 Million USD | 8.24% |
| 2003 Q1 | 334.91 Million USD | 3.66% |
| 2003 Q2 | 343.74 Million USD | 2.64% |
| 2002 Q2 | 314.51 Million USD | 7.06% |
| 2002 Q3 | 314.49 Million USD | -0.0% |
| 2002 Q4 | 323.08 Million USD | 2.73% |
| 2002 FY | 323.08 Million USD | 10.94% |
| 2002 Q1 | 293.76 Million USD | 0.87% |
| 2001 Q1 | 273.69 Million USD | -1.0% |
| 2001 Q4 | 291.23 Million USD | 16.98% |
| 2001 FY | 291.23 Million USD | 5.34% |
| 2001 Q3 | 248.95 Million USD | -3.75% |
| 2001 Q2 | 258.66 Million USD | -5.49% |
| 2000 Q3 | 260.19 Million USD | -5.27% |
| 2000 Q4 | 276.47 Million USD | 6.26% |
| 2000 Q1 | 292.69 Million USD | 2.48% |
| 2000 Q2 | 274.66 Million USD | -6.16% |
| 2000 FY | 276.47 Million USD | -3.2% |
| 1999 FY | 285.6 Million USD | 5.78% |
| 1999 Q4 | 285.6 Million USD | 6.65% |
| 1999 Q3 | 267.8 Million USD | -3.95% |
| 1999 Q2 | 278.8 Million USD | -5.3% |
| 1999 Q1 | 294.4 Million USD | 9.04% |
| 1998 Q1 | 220.1 Million USD | 3.43% |
| 1998 Q3 | 264.8 Million USD | 12.78% |
| 1998 Q4 | 270 Million USD | 1.96% |
| 1998 FY | 270 Million USD | 26.88% |
| 1998 Q2 | 234.8 Million USD | 6.68% |
| 1997 Q2 | 118.2 Million USD | -0.51% |
| 1997 FY | 212.8 Million USD | 68.09% |
| 1997 Q4 | 212.8 Million USD | 40.18% |
| 1997 Q1 | 118.8 Million USD | -6.16% |
| 1997 Q3 | 151.8 Million USD | 28.43% |
| 1996 Q4 | 126.6 Million USD | 19.66% |
| 1996 Q1 | 87.9 Million USD | -8.91% |
| 1996 Q2 | 97.6 Million USD | 11.04% |
| 1996 Q3 | 105.8 Million USD | 8.4% |
| 1996 FY | 126.6 Million USD | 31.19% |
| 1995 Q4 | 96.5 Million USD | 0.0% |
| 1995 FY | 96.5 Million USD | 25.49% |
| 1994 FY | 76.9 Million USD | 0.0% |
| 1994 Q4 | 76.9 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -1212.137% |
| Align Technology, Inc. | 296.9 Million USD | -511.313% |
| Elevance Health Inc. | -46.33 Billion USD | 103.917% |
| AxoGen, Inc. | 23.02 Million USD | -7784.448% |
| Boston Scientific Corporation | 2.48 Billion USD | 26.932% |
| CVS Health Corporation | 18.02 Billion USD | 89.931% |
| Cardinal Health, Inc. | 14.95 Billion USD | 87.865% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -1168.3% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 10.193% |
| Hologic, Inc. | 679.8 Million USD | -166.99% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -377.277% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -282.427% |
| Masimo Corporation | 545 Million USD | -233.028% |
| McKesson Corporation | 21.13 Billion USD | 91.414% |
| Patterson Companies, Inc. | 782.89 Million USD | -131.831% |
| Quest Diagnostics Incorporated | 190 Million USD | -855.263% |
| ResMed Inc. | 822.25 Million USD | -120.736% |
| Teladoc Health, Inc. | 29.51 Million USD | -6049.832% |
| Universal Health Services, Inc. | 216.98 Million USD | -736.452% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 35.729% |
| Becton, Dickinson and Company | 3.27 Billion USD | 44.546% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | -48.697% |
| Danaher Corporation | 2.59 Billion USD | 30.031% |
| Stryker Corporation | 4.84 Billion USD | 62.523% |
| Medtronic plc | 5.21 Billion USD | 65.21% |